Loading company details...
Latest Form 4 (Nov 13, 2026): Mark L. Reisenauer (Director): Grant/Award of 75,364 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Mark L. Reisenauer | Grant/Award | 75,364 | n/a |
| Nov 13, 2026 | Julie B. Feder, Chief Financial Officer | Grant/Award | 164,790 | n/a |
| Nov 13, 2026 | Parameswaran Hari, Chief Medical Officer | Grant/Award | 331,173 | n/a |
| Nov 13, 2026 | Madan Jagasia, Chief Executive Officer | Grant/Award | 678,477 | n/a |
| Aug 5, 2026 | Robert W. Ross | Grant/Award | 37,653 | n/a |
| Aug 5, 2026 | Matthew Norkunas | Grant/Award | 37,653 | n/a |
| Aug 5, 2026 | Peter Barrett | Grant/Award | 37,653 | n/a |
| Aug 5, 2026 | Heidi Hagen | Grant/Award | 37,653 | n/a |
| Aug 5, 2026 | Maria Fardis | Grant/Award | 37,653 | n/a |